Additionally, as in the KAI1 re‐expressing PC3 prostate cancer cells that showed a suppression of both integrin‐ and ligand‐mediated activation of c‐Met,60 the expression of phospho‐c‐MET was also decreased in the KDIP‐injected metastatic liver nodules (Figure 7D). Here, CD82 is linked to prostate carcinoma.